-
1161
Assessment of Artificial Intelligence Models for Developing Single-Value and Loop Rating Curves
Published 2021-01-01“…It was observed that no model outperformed others for all datasets and metrics considered, which demonstrates that the best method may be different from one case to another one. Nevertheless, the ranking analysis indicates that the hybrid MGGP-GRG model overall performs the best in developing stage-discharge relationships for both single-value and loop rating curves. …”
Get full text
Article -
1162
Autologous Fat Grafting Reduces Pain in Irradiated Breast: A Review of Our Experience
Published 2016-01-01“…The follow-up was at 12 months (range 11.7–13.5 months). In 120 treated patients we detected pain decrease (mean ± SD point reduction, 3.19 ± 2.86). …”
Get full text
Article -
1163
Comparison of real-time instrument use and absorbent tube method for measuring formaldehyde in working environments: A health risk assessment for gross anatomy staff
Published 2025-06-01“…The Wilcoxon matched-pairs signed-rank test and intraclass correlation coefficients (ICC) were used to test–retest reliability between the two instruments. …”
Get full text
Article -
1164
Hybrid Harmony Search Algorithm Integrating Differential Evolution and Lévy Flight for Engineering Optimization
Published 2025-01-01“…Comparative analysis with 5 well-known algorithms (HSA, DE, CSA, GA, and PSO) and 4 HSA variants (IHS, MHSA, IHSDE, and IMGHSA) confirmed the robustness of HSA-DELF. …”
Get full text
Article -
1165
Absolute Lymphocyte Count Is Not a Suitable Alternative to CD4 Count for Determining Initiation of Antiretroviral Therapy in Fiji
Published 2014-01-01“…Correlation between the counts in individuals was poor (Spearman rank correlation r=0.5). No absolute lymphocyte count could be determined in this population as a suitable surrogate for a CD4 count of either 350 cells/mm3 or 500 cells/mm3. …”
Get full text
Article -
1166
CADD based designing and biological evaluation of novel triazole based thiazolidinedione coumarin hybrids as antidiabetic agent
Published 2025-02-01“…Abstract A series of 5-(substituted benzylidene) thiazolidine-2,4-dione and coumarin hybrids (I-1 to I-16) were designed and synthesized to explore key structural requirements for effective α-glucosidase inhibitors. …”
Get full text
Article -
1167
Prognostic Factors on the Graft-versus-Host Disease-Free and Relapse-Free Survival after Adult Allogeneic Hematopoietic Stem Cell Transplantation
Published 2016-01-01“…The 1- and 2-year GRFS were 40.8% and 36.5%, respectively, significantly worse than overall survival and disease-free survival (log-rank p<0.001). …”
Get full text
Article -
1168
Analysis of chronic kidney disease epidemiology in Kazakhstan using nationwide data for 2014–2020 and forecasting future trends of prevalence and mortality for 2030
Published 2024-12-01“…According to the Global Burden of Disease (GBD) study, chronic kidney disease (CKD) was prevalent in 697.5 million individuals worldwide in 2017. By 2040, it is anticipated that CKD will rank as the fifth most common cause of death. …”
Get full text
Article -
1169
MRI delta radiomics during chemoradiotherapy for prognostication in locally advanced cervical cancer
Published 2025-01-01“…PFS was evaluated using the Kaplan–Meier method with log-rank tests. Results Deltarad (AUCT/AUCV: 0.74/0.79) marginally outperformed Pre-CCRTrad (0.72/0.75) for predicting 5-year PFS, and both signatures clearly surpassed that of FIGO (0.61/0.61) and Tumormax (0.58/0.65). …”
Get full text
Article -
1170
Exploration of the Immune-Related Signatures and Immune Infiltration Analysis in Melanoma
Published 2021-01-01Get full text
Article -
1171
-
1172
Effectiveness of Inactivated Coronavirus Disease 2019 Vaccine Against Omicron BA.2.2 Infection in Beijing, China, 2022: A Cohabitation Retrospective Cohort Study
Published 2024-12-01“…The VE of the primary in preventing BA.2.2 infection, symptoms, and pneumonia was 37.35% (95% CI: 24.00–48.35), 42.36% (95% CI: 28.41–53.60), and 48.35% (95% CI: −5.34–74.67), respectively. The VE of the booster shot in preventing SARS-CoV-2 infection, symptoms, and pneumonia was 37.08% (95% CI: 24.29–47.70), 44.38% (95% CI: 31.45–54.87), and 61.46% (95% CI: 29.79–78.85), respectively. …”
Get full text
Article -
1173
-
1174
-
1175
-
1176
Inequality and Total Effect Summary Measures for Nominal and Ordinal Variables
Published 2025-02-01Get full text
Article -
1177
-
1178
-
1179
Two-Level Automatic Adaptation of a Distributed User Profile for Personalized News Content Delivery
Published 2008-01-01Get full text
Article -
1180
Evaluación del rol del equipo de coordinación de nefrología en la consulta externa específica de acceso vascular. ¿Qué podemos aportar de nuevo?
Published 2025-02-01“…Tras un tiempo medio en lista de espera de 16,5 ± 11,6 días, excluyendo las ligaduras, se observó una adecuada maduración al mes en el 87,6% de los casos. …”
Get full text
Article